|
|
Article: Cardiac Dimensions[R] Inc. Receives CE Mark for CARILLON[TM] Mitral Contour System[TM].
- Article from:
- Business Wire
- Article date:
- February 2, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Looks Ahead Towards Commercialization Options for Europe
KIRKLAND, Wash. -- Cardiac Dimensions[R], Inc. today announced that on January 26th it received the CE Mark approval for its CARILLON[TM] Mitral Contour System[TM] from KEMA Quality B.V. -- a European Union Notified Body from the Netherlands. The CARILLON[TM] system is a percutaneous treatment for functional mitral regurgitation (FMR). The CE Mark approval is an important milestone for Cardiac Dimensions, allowing the company to market the product in countries that accept CE Marking -- primarily Europe. Cardiac Dimensions is now developing plans for commercialization in Europe.
Prior to the ...